…
BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. It offers private label products with distributors and manufacturing providers. The company also sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www.bioforceeclipse.com, as well as through social media and telemarketing channels. BioForce Nanosciences Holdings, Inc. is based in Virginia Beach, Virginia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -0.49M | -0.49M | -0.47M | -0.49M | -0.50M |
| Net income | -1.29M | -0.49M | -0.47M | -0.49M | -0.50M |
| Selling general administrative | 0.07M | 0.07M | 0.47M | 0.49M | 0.50M |
| Selling and marketing expenses | - | - | - | - | 0.42M |
| Gross profit | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Ebit | - | - | -0.94M | -0.49M | -0.50M |
| Ebitda | -0.49M | -0.49M | -0.47M | -0.49M | -0.50M |
| Depreciation and amortization | - | - | 0.47M | - | - |
| Operating income | -0.49M | -0.49M | -0.47M | -0.49M | -0.50M |
| Other operating expenses | 0.49M | 0.49M | 0.47M | 0.49M | 0.50M |
| Interest expense | - | - | - | - | 0.00M |
| Income tax expense | - | - | -0.47M | - | - |
| Total revenue | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Total operating expenses | 0.49M | 0.49M | 0.47M | 0.49M | 0.50M |
| Cost of revenue | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Total other income expense net | -0.80M | - | -0.00M | - | - |
| Net income from continuing ops | -1.29M | -0.49M | -0.47M | -0.49M | -0.50M |
| Net income applicable to common shares | - | - | - | -0.49M | -0.50M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M |
| Other current assets | - | - | - | - | 0.00M |
| Total liab | 0.62M | 2.30M | 1.82M | 1.35M | 0.87M |
| Total stockholder equity | -0.62M | -2.30M | -1.82M | -1.35M | -0.86M |
| Other current liab | 0.62M | 2.02M | 1.82M | 1.35M | 0.87M |
| Common stock | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M |
| Capital stock | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M |
| Retained earnings | -162.41M | -161.12M | -160.63M | -160.16M | -159.67M |
| Cash | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M |
| Total current liabilities | 0.62M | 2.30M | 1.82M | 1.35M | 0.87M |
| Current deferred revenue | - | - | -0.22M | - | - |
| Net debt | -0.00M | -0.00M | -0.00M | -0.00M | -0.01M |
| Short term debt | - | 0.27M | 0.22M | - | - |
| Short long term debt total | - | - | 0.22M | - | - |
| Other stockholder equity | 161.76M | 158.79M | 158.78M | 158.78M | 158.78M |
| Total current assets | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M |
| Net tangible assets | - | - | - | -1.35M | -0.86M |
| Accounts payable | 0.01M | 0.01M | 0.00M | 0.00M | 0.01M |
| Common stock total equity | - | - | - | - | 0.03M |
| Retained earnings total equity | - | - | - | - | -159.67M |
| Non current assets total | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Change to liabilities | - | - | - | -0.01M | 0.00M |
| Net borrowings | - | - | - | 0.06M | 0.05M |
| Total cash from financing activities | 0.07M | 0.06M | 0.05M | 0.06M | 0.05M |
| Change to operating activities | - | - | - | 0.42M | 0.42M |
| Net income | -1.29M | -0.49M | -0.47M | -0.49M | -0.50M |
| Change in cash | -0.00M | 0.00M | -0.00M | -0.01M | -0.03M |
| Begin period cash flow | 0.00M | 0.00M | 0.00M | 0.01M | 0.04M |
| End period cash flow | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M |
| Total cash from operating activities | -0.07M | -0.06M | -0.05M | -0.07M | -0.08M |
| Issuance of capital stock | 0.00M | 0.01M | 0.00M | 0.00M | - |
| Other cashflows from financing activities | 0.07M | 0.05M | 0.05M | 0.06M | 0.05M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Cash flows other operating | - | - | - | - | -0.00M |
| Cash and cash equivalents changes | - | - | - | - | -0.03M |
| Change in working capital | 0.42M | 0.43M | 0.43M | 0.42M | 0.42M |
| Stock based compensation | 0.42M | 0.42M | - | 0.42M | 0.42M |
| Other non cash items | 0.81M | 0.43M | -0.00M | -0.42M | -0.42M |
| Free cash flow | -0.07M | -0.06M | -0.05M | -0.07M | -0.08M |
Sector: Consumer Defensive Industry: Packaged Foods
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| BFNH BioForce Nanosciences Holdings Inc |
0.44 7.03% |
6.70 | - | - | 3840.95 | 141.43 | 3843.22 | -102.89 |
| NSRGF Nestle SA |
-1.51 1.43% |
104.11 | 26.86 | 18.76 | 3.13 | 7.10 | 3.81 | 21.70 |
| NSRGY Nestle SA ADR |
-2.25 2.11% |
104.18 | 26.82 | 18.66 | 3.18 | 7.07 | 3.81 | 21.70 |
| DANOY Danone PK |
-0.43 2.79% |
14.96 | 24.23 | 17.64 | 1.88 | 2.57 | 1.88 | 11.70 |
| GPDNF Danone S.A |
- -% |
75.84 | 20.30 | 14.75 | 1.65 | 2.24 | 1.76 | 10.92 |
BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. It offers private label products with distributors and manufacturing providers. The company also sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www.bioforceeclipse.com, as well as through social media and telemarketing channels. BioForce Nanosciences Holdings, Inc. is based in Virginia Beach, Virginia.
2020 General Booth Blvd., Virginia Beach, VA, United States, 23454
757 306 6090
3
| Name | Title | Year Born |
|---|---|---|
| Mr. Steven Gagnon | Co-Chief Exec. Officer | 1962 |
| Mr. John LaViolette | Co-Chief Exec. Officer | 1961 |
| Mr. Aleksandr Shapiro | Pres | 1960 |
| Mr. Richard Kaiser | CFO, Corp. Sec., Corp. Governance Officer, Principal Accounting Officer & Director | 1966 |
| Mr. Richard Kaiser | CFO, Corporate Secretary, Corporate Governance Officer, Principal Accounting Officer & Director | 1966 |
| Mr. Steven Gagnon | Co-Chief Executive Officer | 1962 |
| Mr. John LaViolette | Co-Chief Executive Officer | 1962 |
| Mr. Aleksandr Shapiro | President | 1963 |
| Mr. Richard Kaiser | Interim CEO, CFO, Corp Secretary, Corp Governance Officer, Principal Acc Officer & Director | 1966 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.